Advertisement

Topics

Leonard Bell, M.D., Alexion’s Founder, Announces Plans to Retire as Chairman and Board Member

16:05 EST 2 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Board Expects to Appoint Interim CEO, David Brennan, to Succeed Dr. Bell as Chairman Leonard Bell, M.D., Founder of Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), has informed the Board of Directors that he will not stan...

Other Sources for this Article

Alexion:
Media
Stephanie Fagan, 475-230-3777
Senior Vice President, Corporate Communications
or
Kim Diamond, 475-230-3775
Executive Director, Corporate Communications
or
Investors
Elena Ridloff, CFA, 475-230-3601
Vice President, Investor Relations

NEXT ARTICLE

More From BioPortfolio on "Leonard Bell, M.D., Alexion’s Founder, Announces Plans to Retire as Chairman and Board Member"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...